Evidence map›Paper›PMID 33952241›Full record

ArticleJournal of nanobiotechnology2021

The unpredictable carbon nanotube biocorona and a functionalization method to prevent protein biofouling.

Lorena García-Hevia, Mahsa Saramiforoshani, Jorge Monge, Nerea Iturrioz-Rodríguez, Esperanza Padín-González, Fernando González, Lorena González-Legarreta, Jesús González, Mónica L Fanarraga

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Lorena García-Hevia *The Nanomedicine Group, University of Cantabria-IDIVAL, 39011, Santander, Spain. lgarcia@idival.org.ORCID http://orcid.org/0000-0001-8275-7733
Mahsa Saramiforoshani *The Nanomedicine Group, University of Cantabria-IDIVAL, 39011, Santander, Spain.
Jorge MongeOsakidetza, Basque Center for Blood Transfusion and Human Tissues, Galdakao, Spain. Cell Therapy, Stem Cells and Tissues Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Nerea Iturrioz-RodríguezThe Nanomedicine Group, University of Cantabria-IDIVAL, 39011, Santander, Spain.
Esperanza Padín-GonzálezThe Nanomedicine Group, University of Cantabria-IDIVAL, 39011, Santander, Spain.
Fernando GonzálezThe Nanomedicine Group, University of Cantabria-IDIVAL, 39011, Santander, Spain.
Lorena González-LegarretaThe Nanomedicine Group, University of Cantabria-IDIVAL, 39011, Santander, Spain.
Jesús GonzálezThe Nanomedicine Group, University of Cantabria-IDIVAL, 39011, Santander, Spain.
Mónica L FanarragaThe Nanomedicine Group, University of Cantabria-IDIVAL, 39011, Santander, Spain.
Universidad de Cantabria · ESBioCruces Health research Institute · ESPiaggio (Italy) · IT

Funding

Instituto de Salud Carlos III CD17/00105Instituto de Salud Carlos III CD19/00035Instituto de Salud Carlos III DTS19/00033Instituto de Salud Carlos III FI20/00023Instituto de Salud Carlos III PI19/00349
6 · The paper itself

Abstract

backgroundThe intrinsic physicochemical properties of carbon nanotubes (CNTs) make them unique tools in nanotechnology. Their elemental composition, resilience, thermal properties, and surface reactivity make CNTs also of undisputed interest in biotechnology. In particular, their extraordinary ability to capture biomolecules on their surface makes them essential in this field. The proteins adsorbed on the CNTs create a biological coating that endows them the ability to interact with some cell receptors, penetrate membranes or interfere with cell biomechanics, thus behaving as an active bio-camouflage. But some of these proteins unfold, triggering an immune response that unpredictably changes the biological activity of CNTs. For this reason, the control of the biocorona is fundamental in the nanobiotechnology of CNTs.

resultsUsing TEM and AFM here we demonstrate a significant increase in CNTs diameter after protein functionalization. A quantitative analysis using TGA revealed that between 20 and 60% of the mass of functionalized nanotubes corresponds to protein, with single-walled CNTs capturing the highest amounts. To qualitatively/quantitatively characterize these biocoatings, we studied the biochemical "landscape" of the proteins captured by the different nanotubes after functionalization under various conditions. This study revealed a significant variability of the proteins in the corona as a function of the type of nanotube, the functionalization temperature, or the time after exposure to serum. Remarkably, the functionalization of a single type of CNT with sera from various human donors also resulted in different protein landscapes. Given the unpredictable assortment of proteins captured by the corona and the biological implications of this biocoating, we finally designed a method to genetically engineer and produce proteins to functionalize nanotubes in a controlled and customizable way.

conclusionsWe demonstrate the high unpredictability of the spontaneous protein corona on CNTs and propose a versatile functionalization technique that prevents the binding of nonspecific proteins to the nanotube to improve the use of CNTs in biomedical applications.

Indexed as

Blood ProteinsAdsorptionBiofoulingHumansNanotechnologyNanotubes, CarbonProtein CoronaSerumBlood ProteinsNanotubes, CarbonProtein CoronaBiotechnologyCarbonMWCNTSDS-PAGESerumSWCNT

Identifiers

PMID33952241
PMCPMC8097984
OpenAlexW3159072158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.